Correlation of FMF criteria scores with severe preeclampsia - prediction of preeclampsia in first trimester

Mythri R. Bhat; Sunanda N.

doi:10.18203/2320-1770.ijrcog20243930

Authors

Mythri R. Bhat Department of Obstetrics and Gynaecology, Mysore Medical College and Research Institute, Mysore, Karnataka, India
Sunanda N. Department of Obstetrics and Gynaecology, Mysore Medical College and Research Institute, Mysore, Karnataka, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20243930

Keywords:

Preeclampsia prediction algorithm, Fetal medicine foundation algorithm, First trimester preeclampsia prediction

Abstract

Background: For the prediction of Preeclampsia, a combination of tests and risk factors are superior to single predictors, some multivariable screening algorithms have been developed for predicting PE, one of which is developed by the Fetal Medicine Foundation (FMF) which uses maternal history and a combination of biophysical and biochemical measurements between 11+0 to 13+6 weeks gestation. To apply the FMF algorithm for prediction of preeclampsia in the first trimester, on antenatal women admitted with severe preeclampsia by retrospectively using information from their first trimester visits and to determine the sensitivity in the study subjects.

Methods: This is a retrospective study performed using medical records of antenatal women admitted in Cheluvamba Hospital, OBG Department, MMCRI, Mysuru over 12 months period (January 2023 to December 2023) admitted for severe preeclampsia.

Results: A total of 7719 deliveries were recorded in Cheluvamba hospital over the 12 months period. 176 antenatal women were diagnosed with Severe Preeclampsia who delivered during this period and were selected for the study. The FMF Algorithm applied using the information obtained from first trimester records (11+0 to 13+6 weeks) correctly predicted: 85% of early onset preterm Severe PE, 93% of late onset preterm Severe PE, 68% of term Severe PE, 81% of all Severe PE

Conclusion: The availability of this algorithm as a simple, free to use, online website calculator allows primary care physicians at primary care centers to recognise the potential high-risk pregnancy and to start aspirin prophylaxis, refer her to a tertiary care center for further evaluation and adequate follow up care.

Metrics

Metrics Loading ...

References

Braunthal S, Brateanu A. Hypertension in pregnancy: Pathophysiology and treatment. SAGE Open Med. 2019;7:2050312119843700.

American college of obstetricians and gynecologists: hypertension in pregnancy. report of the american college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;10:1022.

American College of Obstetricians and Gynecologists: Low-dose aspirin use during pregnancy. Committee Opinion No. 743, June, 2018

Bartsch E, Medcalf KE, Park AL, Ray JG: Clinical risk factors for preeclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;3:353-753.

Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36(1):56-9.

Rolnik DL, Wright D, Poon LCY, Syngelaki A, Gorman NO, Matallana CP, et al. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2022;50:492-5.

Tan MY, Syngelaki A, Poon LC, Rolnik DL, Gorman NO, Delgado JL, et al: Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2018;52:186-95.

Poon LC, Wright D, Thornton S, Akolekar R, Brocklehurst P, Nicolaides KH. Mini-combined test compared with NICE guidelines for early risk-assessment for pre-eclampsia: the SPREE diagnostic accuracy study. Efficacy Mech Eval. 2020;7(8)

online FMF Criteria calculator Available at: https://fetalmedicine.org/research/assess/preeclampsia/first-trimester. Accessed on 17 March 2024.

Guy GP, Leslie K, Diaz Gomez D, Forenc K, Buck E, Khalil A, et al. Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study. BJOG. 2021;128(2):149–56.

Rocha RS, Gurgel Alves JA, Bezerra Maia EHMS, Araujo Junior E, Martins WP, Vasconcelos CTM, et al. Comparison of three algorithms for prediction preeclampsia in the first trimester of pregnancy. Pregnancy Hypertens. 2017;10:113–7.

Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022;226(2):1071-97.

Ontario Health (Quality). First-trimester screening program for the risk of pre-eclampsia using a multiple-marker algorithm: a health technology assessment. Ont Health Technol Assess Ser. 2022;22(5):1-118.

FOGSI-GESTOSIS-ICOG: Hypertensive Disorders in Pregnancy (HDP) - Good Clinical Practice Recommendations 2019

Gupta M, Yadav P, Yaqoob F. A Prospective Study to Determine the Predictive Ability of HDP-Gestosis Score for the Development of Pre-eclampsia. J Obstet Gynaecol India. 2022;72(6):485-491.

O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, de Alvarado M, et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017;49(6):756–60.

Dubon Garcia A, Devlieger R, Redekop K, Vandeweyer K, Verlohren S, Poon LC. Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium. Pregnancy Hypertens. 2021;25:219–24.